Letters and urgent communications 2012
Topics:
Date published:
Advice from the Chief Medical Officer to HSC professionals for 2012.
Documents
- HSS(MD) 53/2012 18 December 2012 - Confirmed Influenza Isolates in Northern Ireland - NICE Guidance on use of Antivirals now applies
- HSS(MD) 52/2012 11 December 2012 - Vaginal Tapes & Meshes
- HSS(MD) 51/2012 20 November 2012 - Carbon Monoxide Poisoning: ongoing vigilance to ensure recognition and prevention
- HSS(MD) 50/2012 19 November 2012 - Management of Hazard Group 4 Viral Haemorrhagic Fevers and similar human infectious diseases of high consequence
- HSS(MD) 49/2012 16 November 2012 - Availability of and potential severe reactions to AMT and 5-IT
- HSS(MD) 48/2012 14 November 2012 - Revised DHSSPS Consent Forms for Post Mortem Examination
- HSS(MD) 47/2012 1 November 2012 - The surveillance of women at high risk of breast cancer
- HSS(MD) 46/2012 26 October 2012 - Misclassification of Oestrogen Receptor status affecting the treatment of women with breast cancer
- HSS(MD) 45/2012 2 October 2012 - Blood Safety - CMV tested blood components
- HSS(MD) 44/2012 28 September 2012 - Pertussis vaccination programme for pregnant women
- HSS(MD) 43/2012 26 September 2012 - Management of Seasonal Flu 2012/13 - contains appendices
- HSS(MD) 42/2012 25 September 2012 - Novel Coronavirus 2012
- HSS(MD) 41/2012 5 September 2012 - Hantavirus Pulmonary Syndrome (HPS), Yosemite Park, United States of America
- HSS(MD) 40/2012 4 September 2012 - Paracetamol Overdose: New Guidance on use of Intravenous Acetylcysteine - Action Required - contains appendices
- HSS(MD) 39/2012 23 August 2012 - Physiological Early Warning Systems (PEWS) and the management of the deteriorating patient
- HSS(MD) 38/2012 22 August 2012 - Revised HSC Influenza Pandemic Preparedness and Response Guidance: Targeted Stakeholder Consultation
- HSS(MD) 37/2012 14 August 2012 - Update to Guidance on Group B Streptococcus in Pregnancy
- HSS(MD) 36/2012 3 August 2012 - Drug Safety Information changes for Ondansetron
- HSS(MD) 35/2012 1 August 2012 - NI Abdominal Aortic Aneurysm Screening Programme Quality Assurance Standards
- HSS(MD) 34/2012 31 July 2012 - The Seasonal Influenza Vaccination Programme 2012/13 - contains appendices
- HSS(MD) 33/2012 27 July 2012 - Confirmed UK case of Anthrax infection in a person who injected drugs
- HSS(MD) 32/2012 23 July 2012 - Board to Ward Assurance on HCAIs - 'Ten Elements' Aide-Memoire' - contains appendices
- HSS(MD) 31/2012 10 July 2012 - Unavailability of Intravesical BCG for treatment of Bladder Cancer
- HSS(MD) 30/2012 9 July 2012 - HPV Immunisation Programme supply arrangements for Gardasil Vaccine
- HSS(MD) 28/2012 3 July 2012 -Management of Blood Exposure: Role of Emergency Departments
- HSS(MD) 28/2012 3 July 2012 - Management of Blood Exposure: Role of Emergency Departments
- HSS(MD) 27/2012 2 July 2012 - Strategy for Tackling Antimicrobial Resistance (STAR) - contains appendices
- HSS(MD) 26/2012 29 June 2012 - Information on Anthrax, Botulism and Tetanus among drug users
- HSS(MD) 25/2012 26 June 2012 - Severe reactions to Paramethoxyamphetamine (PMA)
- HSS(MD) 24/2012 21 June 2012 - PIP Silicone Breast Implants: Final Report of the Expert Group
- HSS(MD) 23/2012 14 June 2012 - Final Report of the Independent Review of Incidents of Pseudomonas Aeruginosa Infection in Neonatal Units in Northern Ireland
- HSS(MD) 22/2012 - Detection, investigation and management of Anaemia
- HSS(MD0 21/2012 8 June 2012 - Outbreak of Legionnaires' Disease
- HSS(MD) 20/2012 6 June 2012 - End of 2011/12 Flu Season and related issues
- HSS(MD) 19/2012 28 May 2012 - Oral tacrolimus products should be prescribed and dispensed by brand name only to avoid the risk of medication errors - letter from Sir Gordon Duff, Chairman of the Commission on Human Medicines - contains appendices
- HSS(MD) 18/2012 21 May 2012 - Emergency Planning: Patient Group directions for administration of medicines by authorised healthcare personnel to patients exposed to suspected Biological or Radiological Agents
- HSS(MD) 17/2012 15 May 2012 - Guiding principles for the development of decontamination procedures for infant incubators and other specialist equipment for Neonatal Care
- HSS(MD) 16/2012 30 April 2012 - Water Sources & potential Pseudomonas Aeruginosa contamination of taps & water systems - advice for Augmented Care Units - The technical guidance in this letter has been superseded by HSS(MD) 5/2014
- HSS(MD) 15/2012 6 April 2012 - Pseudomonas Update
- HSS(MD) 14/2012 5 April 2012 - Guidance on Death, Stillbirth and Cremation Certification
- HSS(MD) 13/2012 4 April 2012 - Use of Imported Fresh Frozen Plasma (FFP) to treat those born on or after 1 January 1996 and adult patients with TTP
- HSS(MD) 12/2012 28 March 2012 - Best practice on screening for MRSA colonisation
- HSS(MD) 11/2012 15 March 2012 - PIP Silicone Gel Breast Implants supplied before 2001 - updated guidance
- HSS(MD) 10/2012 14 March 2012 - Metal on Metal Hip Replacements
- HSS(MD) 9/2012 7 March 2012 - Severe reactions to potentially Illicit Diazepam
- HSS(MD) 8/2012 24 February 2012 - PIP Silicone Gel Breast Implants - updated guidance
- HSS(MD) 7/2012 17 February 2012 - Suspension of Marketing Authorisation: Teva Levothyroxine 100 microgram tablets & Numark Levothyroxine 100 microgram tablets - letter from Sir Gordon Duff, Chairman of the Commission of Human Medicines & advice from MHRA
- HSS(MD) 6/2012 9 February 2012 - Water sources and potential for Pseudomonas Aeruginosa Infection from taps and water systems - Please note that this has been superseeded by HSS (MD) 06/2017
- HSS(MD) 5/2012 2 February 2012 - Vitamin D - Advice on supplements for at risk groups
- HSS(MD) 4/2012 28 January 2012 - Interim Guidance on Pseudomonas and Neonatal Units
- HSS(MD) 3/2012 20 January 2012 - Legionnaire's Disease cluster associated with Costa Blanca, Spain
- HSS(MD) 2/2012 13 January 2012 - PIP Silicone Gel Breast Implants
- HSS(MD) 1/2012 6 January 2012 - PIP Silicone Gel Breast Implants - contains appendices